3. Clinical scenarios
60 year old female patient, receiving HER2i therapy, FU echo
revealed drop of EF% from 60 % to 45 %, should we continue ?
70 year old male patient, known metastatic lung cancer, presenting
with inferior STEMI, what to do?
20 year old male patient, receiving Immune check point inhibitor
therapy, presenting with shortness of breath, what is the next step?
15. Clinical scenarios
60 year old female patient, receiving HER2i therapy, FU echo
revealed drop of EF% from 60 % to 45 %, should we continue ?
70 year old male patient, known metastatic lung cancer, presenting
with inferior STEMI, what to do?
20 year old male patient, receiving Immune check point inhibitor
therapy, presenting with shortness of breath, what is the next step?
18. Clinical scenarios
60 year old female patient, receiving HER2 therapy, FU echo
revealed drop of EF% from 60 % to 45 %, should we continue ?
70 year old male patient, known metastatic lung cancer, presenting
with inferior STEMI, what to do?
20 year old male patient, receiving Immune check point inhibitor
therapy, presenting with shortness of breath, what is the next step?
35. Clinical scenarios
60 year old female patient, receiving HER2 therapy, FU echo
revealed drop of EF% from 60 % to 45 %, should we continue ?
70 year old male patient, known metastatic lung cancer, presenting
with inferior STEMI, what to do?
20 year old male patient, receiving Immune check point inhibitor
therapy, presenting with shortness of breath, what is the next step?